#biomedicine | XCski&hiker | orophilous ๐‘ฃ๐˜ช๐‘’๐˜ธ๐‘  ๐‘’๐˜น๐‘๐˜ณ๐‘’๐˜ด๐‘ ๐˜ฆ๐‘‘ ๐‘Ž๐˜ณ๐‘’ ๐‘š๐˜บ ๐˜ฐ๐‘ค๐˜ฏ.

Switzerland
Joined March 2020
A new ๐—ฉ๐—ฎ๐˜‚๐—น๐˜+. format for the uncomfortable questions that surface when Bitcoin principles meet real life: #LetterToSatoshi #LTS001 @vaultplus_swiss
#LTS001 โ€” WHEN VERIFYING COSTS TRUST. โ€œDonโ€™t trust. Verify.โ€ sounds simple โ€” until verification reaches people. A #LetterToSatoshi thread. ๐Ÿงต 1/7
85
Gotta Catch 'Em All! Great opportunity by the Great Maestro @HansClevers & team ๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡
Don't miss this organoid symposium in Utrecht, NL! January 19-21 2027 organoids-are-us.com/
16
Building @vaultplus_swiss keeps reinforcing one thing for me: ๐ŸŸง Trust should never scale faster than our ability to verify it. #LetterToSatoshi #LTS002
#LTS002 โ€” WHEN BIG FEELS SAFE. We hesitate to give an email address to a small company โ€” yet hand far more sensitive parts of our lives to institutions simply because they feel safe. But size is not a security model. A #LetterToSatoshi thread. ๐Ÿงต 1/4
19
This is exactly the tension we are building around with @vaultplus_swiss Making #Bitcoin easier without making ownership weaker.
Making cash earn sats is a powerful bridge. The harder question: can we make holding, securing and recovering those sats just as simple w/o giving up sovereignty? Convenience should lead to ownership, not replace it. @jackmallers where do you draw that line? #Bitcoin #SelfCustody
18
Simon L. April-Monn, PhD retweeted
Thanks @BitBoxSwiss for the clarification. With the recent increase in AI phishing attempts (see @swissborg @Coinkite @PocketBitcoin @Ledger @Trezor ..) network users should ๐ค๐ž๐ž๐ฉ ๐ฏ๐ž๐ซ๐ข๐Ÿ๐ฒ๐ข๐ง๐  ๐ข๐ง๐ฌ๐ญ๐ž๐š๐ ๐จ๐Ÿ ๐›๐ฅ๐ข๐ง๐๐ฅ๐ฒ ๐ญ๐ซ๐ฎ๐ฌ๐ญ๐ข๐ง๐ . #LetterToSatoshi #LTS001
1
1
57
Simon L. April-Monn, PhD retweeted
2009. Bitcoin goes live. Stiller Has releases Merci. No, Endo Anaconda wasnโ€™t Satoshi. ๐Ÿ‡โ‚ฟ But the microlearning still lands: 21M makes the unit scarce. It doesnโ€™t make human wants scarce. Better rules matter. So do the humans using them. #LetterToSatoshi #LTS001 #Bitcoin
1
1
10
This goes out to all good people (& also to all bad poeple that spread hate instead of piece) Be kind. Be humble. Be correct. But don't let others put you down for wrong reasons. DE: Lass sie reden... #swiss #entrepreneur #Bligg #CH #Mundart #Bitcoin youtube.com/watch?v=29U4O3qqโ€ฆ
1
73
Simon L. April-Monn, PhD retweeted
๐๐š๐œ๐ค ๐ญ๐จ ๐’๐š๐ญ๐จ๐ฌ๐ก๐ข. Setting up the Vault+ office. Some things are optional. This one wasnโ€™t. Still ๐จ๐ง๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐›๐ž๐ฌ๐ญ ๐ซ๐ž๐š๐๐ฌ ๐ข๐ง ๐๐ข๐ญ๐œ๐จ๐ข๐ง and free for everyone: bitcoin.org/bitcoin.pdf #Bitcoin
1
2
13
Been quiet here for a while. Built something new in the meantime. @vaultplus_swiss is live. #Bitcoin self-custody. Physical. Simple. Yours.
Hello, world. ๐Ÿ‘‹ Vault+ is live. Physical Bitcoin backup. No custody. No seed sharing. No nonsense. Your keys. Your responsibility. Your Bitcoin. Say hello โ†’ tally.so/r/9q0xAE
53
Simon L. April-Monn, PhD retweeted
Postdoc position in our group at @emblebi , analyzing single cell data to better understand and treat neurodegen diseases, collab with @AndrewBassett43 , @mo_lotfollahi, @bayraktar_lab M Strauss and others @OpenTargets . Deadline 20/07. Please share๐Ÿ™: embl.wd103.myworkdayjobs.comโ€ฆ
11
22
2,009
Simon L. April-Monn, PhD retweeted
I recently had the opportunity to speak at #RocheContinents2024! Engaging conversations on the fusion of #art, #science & #sustainability! Don't be afraid to challenge dogma & explore new avenues - you never know what breakthroughs you might find! #Innovation #ThinkOutsideTheBox
3
1
63
3,847
Simon L. April-Monn, PhD retweeted
Science is a career full of rejection & self doubt. Most scientists don't go around collecting awards & kudos but sit there wondering if anyone reads our papers. Telling a scientist whose work you like that you value & appreciate what they do is a small & very meaningful gesture.
7
251
26
1,600
94,042
Simon L. April-Monn, PhD retweeted
Organoids and OoCs aim to improve drug testing and disease modelling, but each suffer from limitations. @milicaruoft discusses their integration to improve cellular hierarchy, structural fidelity, reproducibility, throughput, scale up and efficiency. bit.ly/3RQQuAb
18
2
73
12,234
Good read on advancing #PersonalizedMedicine #stemcells #iPSC #iPSZรผrich Inspiring visions by SHoerstrup & MGenerali @uzh_irem & JTakahashi @kwoltjen @CiRA_KU_E @WyssZurich @KyotoU_News @uzhalumni @uzh_en Let's take the hurdles๐Ÿ‡...
In a few years, weโ€™re likely to see personalized stem cells being used in the first clinical trials for heart patients. But there are still a few hurdles to overcome on the way from the lab to the clinic: news.uzh.ch/en/articles/newsโ€ฆ @uzh_irem
200
Simon L. April-Monn, PhD retweeted
Save the Date! 27. November 2024
2
3
430
๐ŸŽฏlooking forward to attend the lecture by the #organoid #maestro ... congrats @HansClevers #CharlesWeissmannAward #science @UZH_en
It is an honour to announce that our 1st Charles Weissmann Lecture Laureate will be: Prof. Dr. Hans Clevers! He will give his lecture on 5 July at 15:30 in the Aula Magna of the University of Zurich (see flyer attached). Everyone is welcome to attend!!
3
323
Simon L. April-Monn, PhD retweeted
The @snsf_ch and @CH_universities have revised the National Open Access Strategy for a free and immediate access to publicly funded scholarly publications. swissuniversities.ch/fileadmโ€ฆ
9
20
1,689
Simon L. April-Monn, PhD retweeted
Please join us this Thursday for this month's NETChatter beginning at 6pm UK time. Please DM for the link. @LACNETS @NANETS1 @CarcinoidNETs @CureNETs @PheoPara @netcanceraware @netcancerday @HealingNET1 @nitinroper
6
10
833
Simon L. April-Monn, PhD retweeted
Correlation is not causation. In our new perspective, we connect systems biology, causal reasoning, and machine learning to inform future approaches in systems biology and molecular medicine in the wake of current deep learning advances: doi.org/10.1038/s44320-024-0โ€ฆ ๐Ÿงต๐Ÿ‘‡
1
71
5
268
32,761